Scaleable processes for the synthesis of (−)-β-D-2,6-diaminopurine dioxolane (Amdoxovir, DAPD) and (−)-β-D-2-aminopurine dioxolane (APD)

Podobne zapisy

• Synthesis and anti-HIV activity of (-)-β-D-(2R,4R) 1,3-dioxolane 2,6-diamino purine (DAPD) (Amdoxovir) and (-)-β-D-(2R,4R) 1,3-dioxolane guanosine (DXG) prodrugs
  od: Narayanasamy, Janarthanan, i wsp.
  Wydane: (2007)
• Mechanism of Action of 1-β-d-2,6-Diaminopurine Dioxolane, a Prodrug of the Human Immunodeficiency Virus Type 1 Inhibitor 1-β-d-Dioxolane Guanosine
  od: Furman, Phillip A., i wsp.
  Wydane: (2001)
• Pharmacokinetics of (-)-beta-D-2-aminopurine dioxolane and (-)-beta-D-2-amino-6-chloropurine dioxolane and their antiviral metabolite (-)-beta-D-dioxolane guanine in rhesus monkeys.
  od: Chen, H, i wsp.
  Wydane: (1996)
• β-d-2′-C-Methyl-2,6-diaminopurine Ribonucleoside Phosphoramidates are Potent and Selective Inhibitors of Hepatitis C Virus (HCV) and Are Bioconverted Intracellularly to Bioactive 2,6-Diaminopurine and Guanosine 5′-Triphosphate Forms
  od: Zhou, Longhu, i wsp.
  Wydane: (2015)
• Favorable Interactions between Enfuvirtide and 1-β-d-2,6-Diaminopurine Dioxolane In Vitro
  od: Tremblay, Cécile L., i wsp.
  Wydane: (2003)